An expert committee set up to develop the criteria for identifying significant comorbidities present in a person, which would make that person priority individual for Covid-19 vaccination, will finalise its report in the next few days, Niti Aayog Member (Health) VK Paul said on Tuesday.
Apart from Oxford-AstraZeneca ‘s Covishield vaccine and Bharat Biotech’s Covaxin vaccine, there are other vaccines that are in the pipeline, Paul stated.
"The criteria (to identify people with comorbidities) has been developed by a committee.
We are expecting the final report in the next few days," he told PTI.
Paul, who is also the chairman of the National Expert Group On Vaccine Administration for Covid-19 (NEGVAC) said this committee has gone deeply into it and looked at which comorbidities -- the presence of two or more diseases or medical conditions in a patient -- should be kept in mind.
"They are also looking at how to ascertain this, who will certify it, where will the person has go to get the priority vaccine," he said, adding that so the procedural and process issues have also been discussed.
"In this regard, not only the expert committee has met, but also we have had discussions with the state governments," Paul said.